Macromo | LinkedIn (original) (raw)

O nás

Macromo is like having a health coach who perfectly knows your body through DNA, blood work, wearables, and habits. It provides a plan for weight management, enhancing energy and overall health, while keeping you committed to your goals.

Obor

Maloobchod s produkty zdraví a osobní péče

Velikost společnosti

11 - 50 zaměstnanců

Ústředí

Prague

Typ

Soukromá společnost

Datum založení

2021

Speciality

Healthcare, Preventive care, DNA, Personalized healthcare, Healthtech a Bioinformatic

Lokality

Zaměstnanci společnosti Macromo

Aktualizace

• Uživatel Macromo to přesdílel
  
  VC| Oxford MBA | Host of Close Call podcast
  18 h
  🎙️ Close Call Show #12: Insights with Eva Kuttichová, Co-founder of Macromo is out! #motivationmondayI had the privilege of sitting down with Eva, the incredibly resilient and fun person, to discuss her journey and insights into the world of startups, failures, and her hunger to create meaningful products 🚀 💡 Key Highlights from Our Conversation: 1️⃣ The Path to Entrepreneurship: From building small side projects to navigating failures and ultimately creating Macromo. 2️⃣ Balancing Product Design and Leadership: How Eva transitioned from being a product expert to managing key business metrics. 3️⃣ Raising Capital During a Funding Winter:The challenges and lessons of securing funding for a consumer business in tough times. 4️⃣ Avoiding Predatory Termsheets: Why saying *NO* is sometimes the best decision, and Eva’s checklist for acceptable deals. 5️⃣ The Future of Personal Health:Eva’s excitement about where health tech is headed and the opportunities for innovation. 🌟 Eva’s story is a testament to resilience, discipline, and the art of building something meaningful in the health tech space. 👉🏼 Check out the full episode here: https://lnkd.in/ghEGQWsM--- 💬 What’s the biggest lesson you’ve learned while building or scaling a startup? Let me know in the comments! If you're a founder looking for actionable insights, don’t miss this episode. 🎧 #CloseCallPodcast #Entrepreneurship #HealthTech #StartupLessons #WomenInTech #VentureCapital
  
• 
  775 sledujících uživatelů
  2 měs.
  We’re always striving to enhance your experience and have exciting news to share! We’ve reduced the delivery time for our DNA test results from 60 days to an impressive 20-30 days. That makes us one of the fastest in the market #longevity #healthtech
  
• 
  775 sledujících uživatelů
  2 měs.
  Compete in the Longevity leaderboard and win a DNA Premium test! During September, we have prepared a Longevity leaderboard for you to compete for exciting prizes: 1st place - DNA Premium test 2nd place - Digital gift card worth 1500 CZK 3rd place - Digital gift card worth 1000 CZK You can participate by filling out this form. Just enter a few biomarkers and your sports performance. When ranking the results, we take into account your gender and age. You can fill in the form several times during the month if you improve your performance.https://lnkd.in/dEADVbUu #longevity #macromo #dna
  
• Uživatel Macromo to přesdílel
  
  Co-Founder of Macromo, Next Zone | Sigma Squared | ODF16 | Hardware Product Design
  2 měs.
  𝗜𝘀 𝗶𝘁 𝘁𝗿𝘂𝗹𝘆 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲 𝘁𝗼 𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲 𝘆𝗼𝘂𝗿 𝘄𝗵𝗼𝗹𝗲 𝗴𝗲𝗻𝗼𝗺𝗲? 🧬 As genome sequencing costs have plummeted from billions to just a thousand dollars, it's becoming more accessible. But is it practical for the average person? Unfortunately, working with whole genome data still requires specialized knowledge. Reading and interpreting this data is no small task. Bioinformaticians like me often filter out hundreds of genetic mutations that, based on predictions, might seem harmful or crucial for gene function. However, many of these mutations have no real effect on the individual. This makes interpreting the data challenging, as what appears harmful in the genome might not actually be so. So, how do bioinformaticians and geneticists differentiate between significant and insignificant mutations? Here’s an oversimplified overview of how we do it: 𝟭. 𝗟𝗼𝗼𝗸 𝗮𝘁 𝗵𝗼𝘄 𝗽𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝘁 𝘁𝗵𝗲 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻. Mutations that are predicted to have a high impact but are common in the population are less likely to be harmful. If many people have the mutation, any effect it has may be too widespread to be considered pathogenic. 𝟮. 𝗟𝗼𝗼𝗸 𝗮𝘁 𝗵𝗼𝘄 𝘄𝗲𝗹𝗹 𝘁𝗵𝗲 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗰𝗼𝗻𝘀𝗲𝗿𝘃𝗲𝗱 𝗮𝗰𝗿𝗼𝘀𝘀 𝘃𝗮𝗿𝗶𝗼𝘂𝘀 𝗮𝗻𝗶𝗺𝗮𝗹 𝘀𝗽𝗲𝗰𝗶𝗲𝘀. Genes that are conserved across closely related species are likely to be important. If a mutation affects a well-conserved gene, it might be more significant. 𝟯. 𝗟𝗼𝗼𝗸 𝗶𝗳 𝘁𝗵𝗲 𝗺𝘂𝘁𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗽𝗿𝗲𝘀𝗲𝗻𝘁 𝗶𝗻 𝗿𝗲𝗹𝗮𝘁𝗶𝘃𝗲𝘀. If a mutation is found in family members who also show related symptoms or effects, it’s more likely to be important. Many companies offering whole genome sequencing struggle with the challenge of making this complex data understandable for the average person. It has a huge potential to make it understandable for people, and that’s why at Macromo we’re now moving further into the era of whole genome sequencing (WGS) with a new test specifically focused on the following reports, for which we have researched the most up-to-date evidence available. 𝗟𝗼𝗻𝗴𝗲𝘃𝗶𝘁𝘆 𝗮𝗻𝗱 𝗣𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝘃𝗲 𝗠𝘂𝘁𝗮𝘁𝗶𝗼𝗻𝘀 - For example, beneficial mutations in the APOE gene that lower cholesterol levels, decrease Alzheimer’s risk, or mutations in a gene that cause immunity to HIV infection. 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗛𝗲𝗮𝗹𝘁𝗵 - Changes such as in the PCSK9 gene, which can affect blood lipid levels and thus cardiovascular risks. 𝗠𝗲𝘁𝗵𝘆𝗹𝗮𝘁𝗶𝗼𝗻 - The much discussed MTHFR, MTR, and MTRR gene mutations that are linked with higher needs of vitamin B9 and B12 intake to lower homocysteine levels and thus improve overall health. 𝗜𝗻𝗳𝗹𝗮𝗺𝗺𝗮𝘁𝗶𝗼𝗻 - Certain genetic changes in IL-6, IL-1A, IL-1B, and other interleukin group genes can cause a predisposition to higher levels of systemic inflammation. The evidence in this category is unfortunately still very limited.
  
• Uživatel Macromo to přesdílel
  
  Co-Founder of Macromo, Next Zone | Sigma Squared | ODF16 | Hardware Product Design
  3 měs. Upraveno
  Our customer support team at Macromo tells me that many people are asking about the MTHFR gene, methylation, and homocysteine. We're curious about why this topic is suddenly so popular. The gene is important and interesting to study, but most people don't look beyond the hype surrounding it. 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗺𝗲𝘁𝗵𝘆𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗵𝗼𝘄 𝗱𝗼𝗲𝘀 𝗶𝘁 𝗮𝗳𝗳𝗲𝗰𝘁 𝗵𝗼𝗺𝗼𝗰𝘆𝘀𝘁𝗲𝗶𝗻𝗲? People talk about methylation, both positively and negatively, and often mention genes like MTHFR, MTR, and MTRR. Methylation is a chemical process that happens in your body all the time. It adds small "tags" (called methyl groups) to molecules, helping your body control genes and do other important things. The MTHFR gene provides instructions for making an enzyme that changes vitamin B9 into a form needed for methylation. If this gene has mutations, the enzyme may not work as well, leading to fewer methyl groups. Having fewer of those available means that the body cannot convert homocysteine, a naturally occurring amino acid, into its less harmful form. High levels of homocysteine in the blood are linked to heart disease. 𝗣𝗲𝗼𝗽𝗹𝗲 𝗮𝗿𝗲 𝗶𝗻𝘁𝗲𝗿𝗲𝘀𝘁𝗲𝗱 𝗷𝘂𝘀𝘁 𝗶𝗻 𝘁𝗵𝗲 𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗴𝗲𝗻𝗲𝘀, 𝗯𝘂𝘁 𝗱𝗼𝗻'𝘁 𝘀𝗲𝗲 𝗮 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗮 𝗴𝗲𝗻𝗲 𝗮𝗻𝗱 𝗶𝘁𝘀 𝘃𝗮𝗿𝗶𝗮𝗻𝘁. There is a tendency for people to focus on specific genes without distinguishing between the gene itself and its particular variants. People often reach out, wanting us to “measure a specific gene”. The longevity community often highlights multiple genes as influential, but it is essential to recognize that we all possess these genes. Actually, if someone didn’t have some of the genes that the longevity community labels as “bad”, their absence would likely result in serious inborn disease. One example could be the APOE gene, specifically with its APOE4 variant. Unfortunately, the changes in the gene that result in the APOE4 variant do increase various health risks, especially Alzheimer’s, but if someone didn't have the APOE gene at all, it would lead to very serious health problems. This shows that while certain variants of a gene might be linked to health risks, thus people label it as a "bad gene", the gene itself is essential for overall health. 𝗠𝗮𝗰𝗿𝗼𝗺𝗼 𝗶𝘀 𝗺𝗼𝘃𝗶𝗻𝗴 𝗶𝗻 𝘁𝗼 𝗰𝗹𝗮𝗿𝗶𝗳𝘆 𝘁𝗵𝗶𝘀 𝘁𝗼𝗽𝗶𝗰 At Macromo, we're about to launch a new product with more clear, evidence-based reports. The new reports will be well-researched and marked if the scientific evidence is still experimental. One of the new report categories will cover Methylation. Our team is working hard to make sure everyone can easily access and understand information about their DNA, linked with their blood tests and lifestyle data.#longevity #macromo #mthfr #methylation
  
• 
  775 sledujících uživatelů
  3 měs.
  Hlasujte pro Nové Funkce Aplikace Macromo 📱 Aplikaci Macromo se snažíme neustále zlepšovat, aby poskytovala co nejlepší přehled o vašem zdraví. Toho, co by se dalo přidat, je spousta, a proto bychom rádi znali váš názor! Hlasujte zde 👉https://lnkd.in/dY37avQSNové funkce, které zvažujeme: 1. Propojení s Apple Health - Připojte si své chytré hodinky a získávejte týdenní shrnutí vaší aktivity a spánku na dashboardu Macromo. 2. Sdílení dat s lékaři - Sdílejte své výsledky s lékaři ve formátu PDF. 3. Zlepšení nahrávání krevních testů - Nahrávejte vícestránkové testy a získejte importované výsledky instantně. 4. Nahrávání zdravotních zpráv - Digitalizujte si svou zdravotní dokumentaci.#macromo #startup #macromo_cz
  Hlasujte pro nové funkce aplikace Macromo docs.google.com
• Uživatel Macromo to přesdílel
  
  Investor & Managing Partner at Founders Bay | Founder at Women Founders Bay | CTO w/ 4x exits | Connect With Me about Startups, Tech & Diversity 🚀 | Subscribe to receive weekly SF events: newsletter.foundersbay.com
  6 měs. Upraveno
  We no longer want a seat at the table... On Wednesday, with Founders Bay and Edu (Ed) Giansante, we put together our biggest event yet 150 founders, 60 investors, 100 on the waitlist: A pitch competition for women founders. In a landscape where less than 1.9% of funding finds its way to women, we're flipping the script. We are coming together to build a new tech ecosystem, an ecosystem where women come together to fund each other, use each other's products, champion each other's startups, and amplify each other's voices. An ecosystem, where we have equal opportunities to thrive! Our event did just that and we had some amazing startups pitching: Mariana Barona, founder of Synthera AI, providing financial market data, using cutting edge generative AIHeather Hochrein, founder at EVmatch, an electric vehicle charging company that believes everyone deserves access to reliable and convenient EV chargingAnna Yuan, founder of ScaleGrowth AI, a no-code platform for building AI-powered market networks Breeze Liu, founder of Alecto AI , a cross-platform content moderation tool to prevent deep fakesGwyneth Borden, founder at Remynt, revolutionizing debt and credit recovery to provide redemption for credit-challenged consumers.Anandini Chawla, founder of Vara, an AI-powered environmental compliance software solution for manufacturersErika Bahr, founder of Daxe, an AI-powered platform transforming legal diligence processesMorgan M. Stanton, founder at Opal Therapeutics, building new therapeutics in the fields of gynecology and reproductive medicine to improve women's health and quality of life.Eva Kuttichová, founder at Macromo, creating personalized health journey through health coaching and AI. Josephine Declerck, founder of AUR+A Networking, an AR networking app giving you insights, with whom to connect and how to approach them.Shagun Maheshwari, founder of Papaya, a sustainable and more efficient menstrual pad Thank you to our amazing judges for joining us: Hafsa Tahir, Katie Fenner, CFA, Katherine Zhang, Jill Sherman. Thank you to our sponsor Carlos V. with Mir Meridian. ✨ We no longer want a seat at the table — we're building our own damn table, and it's a table where we have equal opportunities to thrive. But, we need your help to make it happen: - Please like and repost this to increase awareness 👍 - Follow the founders and startups on LinkedIn 🚀 - Introduce them to investors, they are all raising! 💡 --- 📩 Subscribe to my newsletter to stay connected with our community: newsletter.foundersbay.com #InvestInWomen #WomenInAI #DiversityInTech #SupportWomenFounders #WomenSupportingWomen #WomenFounders
  • + 4
    
• Uživatel Macromo to přesdílel
  
  804 sledujících uživatelů
  9 měs.
  Kardiovaskulární onemocnění, cukrovka a rakovina patří mezi největší zabijáky Čechů. Důležitou roli zde proto hraje prevence. Český startup Macromo dává pacientům možnost si jednoduše ověřit stav zdraví z pohodlí domova. Stačí odeslat vzorek slin nebo krve a výsledek si pak prohlédnout v mobilní aplikaci. Zákazník Macroma taky dostane radu, jak o sebe správně pečovat. Cílem je, aby se vyhnul možnému onemocnění v budoucnu. Společnost Macromo se zúčastnila akce Týdne inovací 2023, kde nám její spoluzakladatelka Eva Kuttichová poskytla videorozhovor (3:28, s titulky). Kdo patři mezi hlavní zákazníky Macroma? Jak se dá objednat testovací sada? A v čem Macromo supluje funkci státu? Podívejte se na video s Evou Kuttichovou.
  Závažným onemocněním jde přecházet. Stačí k tomu jen vzorek slin či krve https://roklen24.cz
• 
  775 sledujících uživatelů
  10 měs.
  Managing your stress levels is one of the most important tools on your journey toward a better healthier living. Join the webinar organized by Moderní Leader where our colleague Michaela Neprasova will explain what stress is in the first place and teach you effective tactics to manage it better.
  
  607 sledujících uživatelů
  10 měs.
  👀 Věděli jste, že jsme všichni potomci lidí, kteří se uměli nejefektivněji stresovat? 🔵 Ve spolupráci s Michaela Neprasova ze společnosti Macromo jsme vytvořili webinář nabitý technikami a tipy, jak stres pochopit a jak s ním pracovat. Přijďte spolu s námi pochopit svůj stres. Těšíme se na vás na prvním letošním webináři zDARma.
  Tento obsah zde není k dispozici
  Přístup k tomuto a dalšímu obsahu získáte v aplikaci LinkedIn
  

Zaregistrujte se nyní a uvidíte, co vám uteklo

Připojit se nyní

Podobné stránky

Financování